results for the nine-month period of 2019, change of rate more than 20 percent Dear Director and Manager The Stock Exchange of Thailand According to the resolution of the Board of Directors of DOD Biotech
loss compared to the same period of the previous year, which had loss 14.59 million baht. The details as follow: Performance Analysis (1) Revenue Quarter 2-2019 the company and its subsidiaries has total
million baht, an increase of 660.87 million baht or 64.21% of revenue for the same period last year. The increase in income resulted in the net profit for the first half of 2020 equal to 85.53 million baht
-month ended June 30, 2017 as follows: Income Statement For the six-month ended June 30 Change Unit: Million Baht 2017 2016 Amount % Revenues from construction services and sales of construction materials
follow; Consolidated 2Q/2017 2Q/2016 Change Financial Statements (Million Baht) (%) (Million Baht) (%) (%) Revenue from Sales 1,211.6 100.0 % 1,119.8 100.0 % 8.2 % Cost of Sales (827.0) (68.3 %) (725.6
second quarter ended June 30, 2020 which the details are as follows: Unit: million Baht For 3-month period (Apr-Jun) 2020 2019 Change % Increase (Decrease) Revenue from sale of goods 128.52 164.02 (35.50
earnings continue to grow which is the highest quarterly profit statistics. The net profit report 226.9 million Baht in Q2/2020. The company had the same amount of collection in the first half of the year
financial statements Q2-2022 Q1-2023 Q2-2023 Change 6M-2022 6M-2023 Change THB Mn THB Mn THB Mn %QoQ %YoY THB Mn THB Mn %YoY Sales of goods and services 1,542.4 1,638.2 1,508.8 (7.9%) (2.2%) 3,061.1 3,147.0
as follow: Revenue from Sales The Company has revenue from sales in the first quarter in the amount of 1,110.0 million Baht decreased by 13.3 percent compared to the same quarter of the previous year